Wells Fargo & Company Fulgent Genetics, Inc. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
1 transactions
Others Institutions Holding FLGT
# of Institutions
195Shares Held
15.3MCall Options Held
1.07MPut Options Held
27.9K-
Black Rock Inc. New York, NY3.92MShares$85.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$31.2 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.22MShares$26.4 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny959KShares$20.8 Million0.01% of portfolio
-
Park West Asset Management LLC Larkspur, CA833KShares$18.1 Million1.3% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $657M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...